Skip to main content
Clinical Trials/ISRCTN34690731
ISRCTN34690731
Completed
未知

Multi-modality imaging to determine the role of calcification and inflammation on restenosis rates following lower limb angioplasty: The CIRLA Study

British Heart Foundation0 sites50 target enrollmentAugust 15, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Peripheral Arterial Disease
Sponsor
British Heart Foundation
Enrollment
50
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

2019 results in https://pubmed.ncbi.nlm.nih.gov/31202739/ (added 08/04/2020)

Registry
who.int
Start Date
August 15, 2017
End Date
October 1, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 50 years or over (women aged 55 years or over)
  • 2\. Symptomatic peripheral arterial disease (intermittent claudication / critical limb ischaemia)
  • 3\. Undergoing superficial femoral artery angioplasty (PTA) or femoro\-popliteal vein bypass graft (FPBG)
  • 4\. Patients with TASC A and B lesions for the PTA group (there will be no restriction with regard to disease severity on the FPBG group as long as the anastomosis is to the popliteal artery)
  • 5\. Taking standard antiplatelet/statin medication

Exclusion Criteria

  • 1\. Inability to undergo PET/CT
  • 2\. Presence of end stage renal failure
  • 3\. Metastatic malignancy
  • 4\. Patients undergoing adjunct endovascular procedures in the infrainguinal segments – PTA group only (e.g. Bare Metal Stent, Drug Eluting Balloon, Drug Eluting Stent)
  • 5\. Previous ipsilateral femoral artery angioplasty within the previous 6 months – PTA group only
  • 6\. Women under the age of 55 years
  • 7\. Patients with diabetes mellitus taking insulin

Outcomes

Primary Outcomes

Not specified

Similar Trials